Article

Cataracts could be detected early with NASA device

Researchers are studying the use of a NASA device to reveal the development of cataracts before a patient's vision clouds over.

Washington, DC-Researchers are studying the use of a NASA device to reveal the development of cataracts before a patient’s vision clouds over. The noninvasive test can determine whether the eyes are losing the natural compound that keeps cataracts at bay.

The device also would allow for easier testing of whether certain medications might slow or prevent cataracts from forming in the first place. People who knew they were vulnerable to cataracts could respond by reducing risk, for example, by avoiding cigarette smoke, improving their diet, and wearing sunglasses.

Research began when Rafat Ansari, a NASA senior scientist with the agency’s John Glenn Research Center in Cleveland, developed a low-powered laser light device to assist astronauts with experiments growing crystals in space. Since his space laser measures proteins that make up crystals, Ansari invested whether the device also could spot cataract-related proteins.

At the National Eye Institute, researchers tested 235 people ages 7 to 86 and found that alpha-crystallin decreased consistently both as lenses began to fog and as people with clear lenses aged.

"What we are really looking at is the reserve of this alpha-crystallin," Ansari told the Associated Press. It can "repair any damage if there is a certain concentration. If it depletes below that level then I think the game is over,” he said.

Researchers with NASA and the National Institutes of Health are now planning separate studies to see whether special formulations of antioxidants can slow the loss of alpha-crystallin.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.